Literature DB >> 19461912

Hemobilia as a potential complication in patients treated with photodynamic therapy for unresectable cholangiocarcinoma.

Ronan P Killeen1, William C Torreggiani, Dermot E Malone, David P Brophy.   

Abstract

Entities:  

Year:  2009        PMID： 19461912      PMCID： PMC2684720     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  4 in total

1.  Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.

Authors:  Thomas Zoepf; Ralf Jakobs; Joachim C Arnold; Darius Apel; Jürgen F Riemann
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

2.  Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.

Authors:  Marianne E J Ortner; Karel Caca; Frieder Berr; Jochen Liebetruth; Ulrich Mansmann; Dominik Huster; Winfried Voderholzer; Guido Schachschal; Joachim Mössner; Herbert Lochs
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

3.  Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.

Authors:  Marcus Wiedmann; Karel Caca; Frieder Berr; Ingolf Schiefke; Andrea Tannapfel; Christian Wittekind; Joachim Mössner; Johann Hauss; Helmut Witzigmann
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

4.  Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma.

Authors:  Joseph M Baisden; Michel Kahaleh; Geoffrey R Weiss; Hilary Sanfey; Christopher A Moskaluk; Paul Yeaton; Eduard E de Lange; Tyvin A Rich
Journal:  Gastrointest Cancer Res       Date:  2008-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.